Fuller Brian M, Gajera Mithil, Schorr Christa, Gerber David, Dellinger R Phillip, Parrillo Joseph, Zanotti Sergio
Department of Anesthesiology, Division of Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Emerg Med. 2012 Oct;43(4):593-8. doi: 10.1016/j.jemermed.2012.01.038. Epub 2012 Mar 24.
The exact role of packed red blood cell (PRBC) transfusion in the setting of early resuscitation in septic shock is unknown.
To evaluate whether PRBC transfusion is associated with improved central venous oxygen saturation (ScvO(2)) or organ function in patients with severe sepsis and septic shock receiving early goal-directed therapy (EGDT).
Retrospective cohort study (n=93) of patients presenting with severe sepsis or septic shock treated with EGDT.
Thirty-four of 93 patients received at least one PRBC transfusion. The ScvO(2) goal>70% was achieved in 71.9% of the PRBC group and 66.1% of the no-PRBC group (p=0.30). There was no difference in the change in Sequential Organ Failure Assessment (SOFA) score within the first 24 h in the PRBC group vs. the no-PRBC group (8.6-8.3 vs. 5.8-5.6, p=0.85), time to achievement of central venous pressure>8 mm Hg (732 min vs. 465 min, p=0.14), or the use of norepinephrine to maintain mean arterial pressure>65 mm Hg (81.3% vs. 83.8%, p=0.77).
In this study, the transfusion of PRBC was not associated with improved cellular oxygenation, as demonstrated by a lack of improved achievement of ScvO(2)>70%. Also, the transfusion of PRBC was not associated with improved organ function or improved achievement of the other goals of EGDT. Further studies are needed to determine the impact of transfusion of PRBC within the context of early resuscitation of patients with septic shock.
在脓毒性休克早期复苏过程中,浓缩红细胞(PRBC)输注的确切作用尚不清楚。
评估在接受早期目标导向治疗(EGDT)的严重脓毒症和脓毒性休克患者中,PRBC输注是否与中心静脉血氧饱和度(ScvO₂)改善或器官功能改善相关。
对接受EGDT治疗的严重脓毒症或脓毒性休克患者进行回顾性队列研究(n = 93)。
93例患者中有34例接受了至少一次PRBC输注。PRBC组71.9%的患者实现了ScvO₂目标>70%,无PRBC组为66.1%(p = 0.30)。PRBC组与无PRBC组在前24小时内序贯器官衰竭评估(SOFA)评分的变化(8.6 - 8.3 vs. 5.8 - 5.6,p = 0.85)、达到中心静脉压>8 mmHg的时间(732分钟 vs. 465分钟,p = 0.14)或使用去甲肾上腺素维持平均动脉压>65 mmHg方面(81.3% vs. 83.8%,p = 0.77)均无差异。
在本研究中,PRBC输注与细胞氧合改善无关,这表现为未实现ScvO₂>70%的改善。此外,PRBC输注与器官功能改善或EGDT其他目标的实现改善无关。需要进一步研究以确定在脓毒性休克患者早期复苏背景下PRBC输注的影响。